摘要
目的 总结异基因造血干细胞移植后合并EB病毒相关的淋巴细胞增殖性疾病（EBV-PTLD）患者的护理措施.方法 对2014年10月至2016年5月收治的5例异基因造血干细胞移植合并EBV-PTLD患者的护理措施进行总结和分析.结果 经过治疗与护理,3例患者好转出院,1例患者病情加重,出现呼吸衰竭、癫痫、肝功能衰竭、弥散性血管内凝血,自动出院,死亡.1例并发其他疾病死亡.结论 EB病毒感染是异基因造血干细胞移植后的合并症,病死率高,定期监测、早期诊断、及早干预,有效、及时、积极的治疗与护理是防治EB病毒感染的关键.
Objective To summarize the nursing care measures about patients with Epstein-Barr virus related post-transplantation lymphoproliferative disorder （EBV-PTLD） after allogeneic hematopoietic stem cell transplantation. Methods The nursing care measures about five patients with EBV-PTLD after allogeneic hematopoietic stem cell transplantation from October 2014 to May 2015 were summarized and analyzed. Results After carefully treating and nursing care, three patients were discharged. One patient with exacerbations, respiratory, epilepsy, liver failure, and disseminated intravascular coagulation was automatically discharged and then died. And the other patient died of other diseases. Conclusions Epstein-Barr virus infection is a complication after allogeneic hematopoietic stem cell transplantation. The key points to prevention and treatment of EBV infection included monitoring regularly, diagnosing and early intervention, which was proved to be effective, timely and active.
出处
《中国实用护理杂志》
2017年第16期1227-1230,共4页
Chinese Journal of Practical Nursing
基金
北京协和青年科研基金资助项目（2012H05）
关键词
护理
异基因造血干细胞移植
EB病毒
淋巴细胞增殖性疾病
利妥昔单抗
Nursing care
Allogeneic hematopoietic stem cell transplantation
Epstein-Barr virus
Post-transplantation lymphoproliferative disorder
Rituximab
